This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
G or EXLS: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
G vs. EXLS: Which Stock Is the Better Value Option?
Accenture Launches Personalized Experiences on Salesforce
by Zacks Equity Research
The move is part of ACN's growth strategy that focuses on delivering 360?? value to its stakeholders.
Accenture Ventures Adds EMTECH to its Investment Portfolio
by Zacks Equity Research
The investment seems integral to ACN's broader growth strategy, which emphasizes delivering comprehensive value through technology.
Accenture and Unilever Collaborate on Generative AI Platform
by Zacks Equity Research
ACN's collaboration with UL marks a strategic move toward strengthening its position as a leader in digital transformation.
Are Investors Undervaluing Genpact (G) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
VoLT Strategy Drives Booz Allen's Success Amid Rising Expenses
by Zacks Equity Research
BAH leverages its VoLT strategy to improve market position, scale businesses and grow its technology and solutions.
Is Limbach (LMB) Stock Outpacing Its Business Services Peers This Year?
by Zacks Equity Research
Here is how Limbach (LMB) and Genpact (G) have performed compared to their sector so far this year.
Envestnet Stock Appreciates 27% Year to Date: Here's What to Know
by Zacks Equity Research
ENV's business model ensures solid asset- and subscription-based recurring revenue-generation capacity.
Why Genpact (G) is a Top Value Stock for the Long-Term
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here's Why You Should Add FactSet Stock in Your Portfolio Now
by Zacks Equity Research
FDS has a consistent track record of rewarding its shareholders through share repurchases and dividends.
Here's Why You Should Retain Broadridge Financial Stock Now
by Zacks Equity Research
BR is executing well on its growth strategy in governance, capital markets and wealth management.
Zacks.com featured highlights Genpact, MPLX, Exelixis, Paramount Global and H&R Block
by Zacks Equity Research
Genpact, MPLX, Exelixis, Paramount Global and H&R Block have been highlighted in this Screen of The Week article.
G vs. EXLS: Which Stock Is the Better Value Option?
by Zacks Equity Research
G vs. EXLS: Which Stock Is the Better Value Option?
5 Top-Ranked Value Stocks With Discounted PEG Ratio to Buy
by Urmimala Biswas
Five PEG-based stocks that fulfill our screening criteria are Genpact, MPLX, Exelixis, Paramount Global and H&R Block.
Why You Should Retain Corpay Stock in Your Portfolio Now
by Zacks Equity Research
CPAY has been consistently pursuing acquisitions and investments to increase its customer base, workforce and operational capabilities.
Genpact (G) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
Reasons Why You Should Hold Rollins (ROL) Stock Now
by Zacks Equity Research
Rollins (ROL) has a track record of consistent dividend payments.
Here's Why H&R Block (HRB) Stock is a Great Pick Right Now
by Zacks Equity Research
The main drivers of H&R Block's (HRB) post-pandemic performance are digital enablement of business, client addition and retention, and greater usage of AI.
Reasons Why You Should Bet on Charles River (CRAI) Stock Now
by Zacks Equity Research
Commitment to shareholder returns makes Charles River (CRAI) a reliable way for investors to compound wealth over the long term.
CEB Acquisition Benefits Gartner (IT) Amid Tough Competition
by Zacks Equity Research
Gartner (IT) is gaining from its ability to provide insights using data collected by advanced technologies.
Is First Trust Industrials/Producer Durables AlphaDEX ETF (FXR) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for FXR
Is Cellebrite DI Ltd. (CLBT) Stock Outpacing Its Business Services Peers This Year?
by Zacks Equity Research
Here is how Cellebrite DI Ltd. (CLBT) and Genpact (G) have performed compared to their sector so far this year.
Is Genpact (G) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Genpact Limited (G) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Genpact (G) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Genpact's (G) Q2 Earnings Surpass Estimates, Increase Y/Y
by Zacks Equity Research
Genpact's (G) second-quarter 2024 earnings and revenues increase on a year-over-year basis.